Granules India informs about press release

31 Jan 2022 Evaluate

Granules India has informed that it enclosed the press release on January 31st ,2022 titled ‘Granules Pharmaceuticals, Inc. concludes US FDA Audit with Three Minor Observations’.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

542.35 -18.30 (-3.26%)
08-Dec-2025 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1790.05
Dr. Reddys Lab 1272.70
Cipla 1498.90
Zydus Lifesciences 924.35
Lupin 2061.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×